Phibro Animal Health Corporation Reports Second Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health Corp. (PAHC) PT Raised to $34 at Piper Jaffray
February 8, 2017 9:17 AM ESTPiper Jaffray raised its price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $34.00 (from $32.00) while maintaining a Overweight rating. Phibro reported in-line revenues and upside to earnings for 2Q17, where revenues of $192M were only slightly below the Street's estimates of $193M, while... More
Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
February 6, 2017 4:18 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $191.6 million versus the consensus estimate of $192.92 million.
FINANCIAL GUIDANCE
We have reaffirmed our financial guidance for the fiscal year 2017 as initially... More



